Born in the lab

Our co-founders developed SPEAR (Successive Proximity Extension Amplification Reaction) technology through groundbreaking research at the Wyss Institute for Biologically Inspired Engineering. They founded Spear Bio to realize the full potential of this technology, developing high-impact immunoassays that can be easily adopted by academic and clinical researchers and practitioners.

Quality at every step

Spear Bio is committed to the highest standards of quality throughout our processes. Our Quality Management System is certified to ISO 13485:2016, providing assurance that our SPEAR platform delivers results that the research and medical community can rely on.

VIEW OUR ISO CERTIFICATE

quote-icon

“Our goal is to build the world’s most sensitive immunoassay platform and deliver assays we are proud to put in our customers’ hands to address critical scientific and clinical challenges.”

– Feng Xuan Ph.D., Spear Bio CEO and Co-founder

Connect with Spear Bio

To learn how our technology can aid your biomarker investigation, let’s talk.

cta image